Pfizer Inc (PFE)
27.52
+0.34
(+1.27%)
USD |
NYSE |
May 02, 11:05
Pfizer Price to Book Value: 1.746 for May 2, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
May 01, 2024 | 1.724 |
April 30, 2024 | 1.625 |
April 29, 2024 | 1.626 |
April 26, 2024 | 1.611 |
April 25, 2024 | 1.602 |
April 24, 2024 | 1.666 |
April 23, 2024 | 1.670 |
April 22, 2024 | 1.666 |
April 19, 2024 | 1.649 |
April 18, 2024 | 1.611 |
April 17, 2024 | 1.613 |
April 16, 2024 | 1.630 |
April 15, 2024 | 1.644 |
April 12, 2024 | 1.640 |
April 11, 2024 | 1.671 |
April 10, 2024 | 1.670 |
April 09, 2024 | 1.699 |
April 08, 2024 | 1.686 |
April 05, 2024 | 1.691 |
April 04, 2024 | 1.691 |
April 03, 2024 | 1.727 |
April 02, 2024 | 1.748 |
April 01, 2024 | 1.758 |
March 28, 2024 | 1.760 |
March 27, 2024 | 1.762 |
Date | Value |
---|---|
March 26, 2024 | 1.750 |
March 25, 2024 | 1.740 |
March 22, 2024 | 1.736 |
March 21, 2024 | 1.755 |
March 20, 2024 | 1.757 |
March 19, 2024 | 1.753 |
March 18, 2024 | 1.758 |
March 15, 2024 | 1.772 |
March 14, 2024 | 1.784 |
March 13, 2024 | 1.790 |
March 12, 2024 | 1.777 |
March 11, 2024 | 1.800 |
March 08, 2024 | 1.727 |
March 07, 2024 | 1.700 |
March 06, 2024 | 1.725 |
March 05, 2024 | 1.654 |
March 04, 2024 | 1.642 |
March 01, 2024 | 1.687 |
February 29, 2024 | 1.685 |
February 28, 2024 | 1.715 |
February 27, 2024 | 1.706 |
February 26, 2024 | 1.724 |
February 23, 2024 | 1.761 |
February 22, 2024 | 1.748 |
February 21, 2024 | 1.755 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.522
Minimum
Dec 14 2023
4.542
Maximum
Dec 16 2021
2.926
Average
3.069
Median
Price to Book Value Benchmarks
Amgen Inc | 23.87 |
Johnson & Johnson | 5.155 |
Eli Lilly and Co | 56.73 |
Viking Therapeutics Inc | 8.837 |
Moderna Inc | 3.301 |
Price to Book Value Related Metrics
PE Ratio | 76.46 |
PS Ratio | 2.674 |
Price to Free Cash Flow | 32.64 |
Price | 27.52 |
Earnings Yield | 1.31% |
Market Cap | 155.43B |
Operating PE Ratio | 46.57 |
Normalized PE Ratio | 25.86 |